Abstract
The p16INK4a tumour suppressor accumulates in many tissues as a function of advancing age1,2,3. p16INK4a is an effector of senescence4,5 and a potent inhibitor of the proliferative kinase Cdk4 (ref. 6), which is essential for pancreatic β-cell proliferation in adult mammals7,8. Here we show that p16INK4a constrains islet proliferation and regeneration in an age-dependent manner. Expression of the p16INK4a transcript is enriched in purified islets compared with the exocrine pancreas, and islet-specific expression of p16INK4a, but not other cyclin-dependent kinase inhibitors, increases markedly with ageing. To determine the physiological significance of p16INK4a accumulation on islet function, we assessed the impact of p16INK4a deficiency and overexpression with increasing age and in the regenerative response after exposure to a specific β-cell toxin. Transgenic mice that overexpress p16INK4a to a degree seen with ageing demonstrated decreased islet proliferation. Similarly, islet proliferation was unaffected by p16INK4a deficiency in young mice, but was relatively increased in p16INK4a-deficient old mice. Survival after toxin-mediated ablation of β-cells, which requires islet proliferation, declined with advancing age; however, mice lacking p16INK4a demonstrated enhanced islet proliferation and survival after β-cell ablation. These genetic data support the view that an age-induced increase of p16INK4a expression limits the regenerative capacity of β-cells with ageing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
196,21 € per year
only 3,85 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Zindy, F., Quelle, D. E., Roussel, M. F. & Sherr, C. J. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15, 203–211 (1997)
Krishnamurthy, J. et al. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299–1307 (2004)
Nielsen, G. P. et al. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab. Invest. 79, 1137–1143 (1999)
Park, I. K., Morrison, S. J. & Clarke, M. F. Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113, 175–179 (2004)
Campisi, J. Cancer and ageing: rival demons? Nature Rev. Cancer 3, 339–349 (2003)
Lowe, S. W. & Sherr, C. J. Tumor suppression by Ink4a–Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77–83 (2003)
Rane, S. G. et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nature Genet. 22, 44–52 (1999)
Tsutsui, T. et al. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27Kip1 activity. Mol. Cell. Biol. 19, 7011–7019 (1999)
Halvorsen, T. L., Beattie, G. M., Lopez, A. D., Hayek, A. & Levine, F. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J. Endocrinol. 166, 103–109 (2000)
Kushner, J. A. et al. Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth. Mol. Cell. Biol. 25, 3752–3762 (2005)
Hino, S. et al. In vivo proliferation of differentiated pancreatic islet β cells in transgenic mice expressing mutated cyclin-dependent kinase 4. Diabetologia 47, 1819–1830 (2004)
Marzo, N. et al. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased β cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic β cell mass regeneration in Type 1 diabetes. Diabetologia 47, 686–694 (2004)
Pei, X. H., Bai, F., Tsutsui, T., Kiyokawa, H. & Xiong, Y. Genetic evidence for functional dependency of p18Ink4c on Cdk4. Mol. Cell. Biol. 24, 6653–6664 (2004)
Montana, E., Bonner-Weir, S. & Weir, G. C. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J. Clin. Invest. 91, 780–787 (1993)
Fernandes, A. et al. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology 138, 1750–1762 (1997)
Uchida, T. et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nature Med. 11, 175–182 (2005)
Sharpless, N. E. et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413, 86–91 (2001)
Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H. & DePinho, R. A. The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis. Oncogene 23, 379–385 (2004)
Bonner-Weir, S., Trent, D. F., Honey, R. N. & Weir, G. C. Responses of neonatal rat islets to streptozotocin: limited β-cell regeneration and hyperglycemia. Diabetes 30, 64–69 (1981)
Riley, W. J., McConnell, T. J., Maclaren, N. K., McLaughlin, J. V. & Taylor, G. The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age. Diabetes 30, 718–723 (1981)
Gu, D., Arnush, M. & Sarvetnick, N. Endocrine/exocrine intermediate cells in streptozotocin-treated Ins-IFN-γ transgenic mice. Pancreas 15, 246–250 (1997)
Meng, A., Wang, Y., Van Zant, G. & Zhou, D. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res. 63, 5414–5419 (2003)
Wang, Y., Schulte, B. A., Larue, A. C., Ogawa, M. & Zhou, D. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 107, 358–366 (2006)
Jacobs, J. J. & de Lange, T. Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr. Biol. 14, 2302–2308 (2004)
Robles, S. J. & Adami, G. R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16, 1113–1123 (1998)
Molofsky, A. V. et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature advance online publication, doi:10.1038/nature05091 (6 September 2006).
Janzen, V. et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature advance online publication, doi:10.1038/nature05159 (6 September 2006).
Dor, Y., Brown, J., Martinez, O. I. & Melton, D. A. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41–46 (2004)
Bonner-Weir, S. & Weir, G. C. New sources of pancreatic β-cells. Nature Biotechnol. 23, 857–861 (2005)
Sone, H. & Kagawa, Y. Pancreatic β cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48, 58–67 (2005)
Butler, A. E. et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102–110 (2003)
Yoon, K. H. et al. Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J. Clin. Endocrinol. Metab. 88, 2300–2308 (2003)
Acknowledgements
We thank J. Lock, S. Alson, M. Zhang, Y. Xiong and G. Enders for advice, reagents and technical support, and R. DePinho and K. Wong for comments on the manuscript. This work was supported by grants from the Sidney Kimmel Cancer Foundation for Cancer Research, the Paul Beeson Physician Scholars program, the Ellison Medical Foundation, and the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.
Supplementary information
Supplementary Figures
This file contains Supplementary Figures 1–6. (PPT 3538 kb)
Supplementary Notes
DThis file contains the Supplementary Methods, Supplementary Figure Legends, Supplementary Table 1 and additional references. (DOC 75 kb)
Rights and permissions
About this article
Cite this article
Krishnamurthy, J., Ramsey, M., Ligon, K. et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453–457 (2006). https://doi.org/10.1038/nature05092
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature05092
This article is cited by
-
Loss of p16 does not protect against premature ovarian insufficiency caused by alkylating agents
BMC Pregnancy and Childbirth (2023)
-
Association between very advanced maternal age women with gestational diabetes mellitus and the risks of adverse infant outcomes: a cohort study from the NVSS 2014–2019
BMC Pregnancy and Childbirth (2023)
-
Multiparity increases the risk of diabetes by impairing the proliferative capacity of pancreatic β cells
Experimental & Molecular Medicine (2023)
-
Research on the anti-ageing mechanism of Prunella vulgaris L.
Scientific Reports (2023)
-
Inflammation and DNA damage: cause, effect or both
Nature Reviews Rheumatology (2023)